In summary, it is speculated that serum Adropin levels, which reflect ENHO expression within the tumor microenvironment, may more accurately represent the true role of ENHO in cancer, particularly in PAAD patients. The gene discussed is ENHO; the disease is pancreatic adenocarcinoma.